Moderna Or BioNTech: Which mRNA Stock Should You Pick?

Messenger RNA technology leaders Moderna and BioNTech have seen their stocks rally by around 75% and 150% respectively year-to-date driven by strong demand for their Covid-19 shots and also as investors see tremendous potential in leveraging mRNA technology beyond Covid, to fight a variety of… Forbes – Money | Read More

Similar Posts

Leave a Reply

Your email address will not be published.